Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Vanda Pharmaceuticals Inc (VNDA)

  • SEC News
  • Jan. 09, 2026, 21:24 UTC
  • 5
  • 0 comments

New Form SCHEDULE 13G/A - Vanda Pharmaceuticals Inc. Filed: 2026-01-09 AccNo: 0001104659-26-002483 Size: 15 KB

Comment Full text

Mineralys Therapeutics Inc (MLYS)

  • SEC News
  • Jan. 09, 2026, 21:23 UTC
  • 5
  • 1 comments

📋 Rodman David Malcom (Officer) plans to sell 2K shares of Mineralys Therapeutics, Inc. (at $33.27 each, total $72K) Filed: Jan 09, 2026 | ID: 000032

Comment Full text

Acumen Pharmaceuticals Inc (ABOS)

  • SEC News
  • Jan. 09, 2026, 21:22 UTC
  • 3
  • 1 comments

📋 Meisner Derek M (Officer) plans to sell 5K shares of Acumen Pharmaceuticals, Inc. (at $1.76 each, total $9K) Filed: Jan 09, 2026 | ID: 000031

Comment Full text

Revolution Medicines Inc (RVMD)

  • SEC News
  • Jan. 09, 2026, 21:20 UTC
  • 3
  • 1 comments

Anders Jack 🟡 adjusted position in 10.0K shares (1 derivative) of Revolution Medicines, Inc. (RVMD) at $98.00 ($1.8M) Transaction Date: Jan 07, 2026 | Filing ID: 000012

Comment Full text

Acumen Pharmaceuticals Inc (ABOS)

  • SEC News
  • Jan. 09, 2026, 21:20 UTC
  • 4
  • 1 comments

📋 OConnell Daniel Joseph (Officer) plans to sell 13K shares of Acumen Pharmaceuticals, Inc. (at $1.76 each, total $23K) Filed: Jan 09, 2026 | ID: 000030

Comment Full text

Perrigo Company plc (PRGO)

  • Business News
  • Jan. 09, 2026, 21:20 UTC
  • 11
  • 1 comments

Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Monte Rosa Therapeutics (GLUE)

  • SEC News
  • Jan. 09, 2026, 21:19 UTC
  • 7
  • 0 comments

New Form SCHEDULE 13D/A - Monte Rosa Therapeutics, Inc. Filed: 2026-01-09 AccNo: 0001193125-26-008951 Size: 18 KB

Comment Full text

Neumora Therapeutics Inc. (NMRA)

  • SEC News
  • Jan. 09, 2026, 21:19 UTC
  • 5
  • 1 comments

Aurora Daljit Singh 🟢 acquired 750.0K shares (1 derivative) of Neumora Therapeutics, Inc. (NMRA) at $2.33 ($1.7M) Transaction Date: Jan 08, 2026 | Filing ID: 000011

Comment Full text

Neumora Therapeutics Inc. (NMRA)

  • SEC News
  • Jan. 09, 2026, 21:18 UTC
  • 7
  • 1 comments

Duncan Jason 🟢 acquired 750.0K shares (1 derivative) of Neumora Therapeutics, Inc. (NMRA) at $2.33 ($1.7M) Transaction Date: Jan 08, 2026 | Filing ID: 000010

Comment Full text

IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)

  • SEC News
  • Jan. 09, 2026, 21:18 UTC
  • 7
  • 1 comments

📋 Patel Anish (Officer) plans to sell 48K shares of Enliven Therapeutics, Inc. (at $23.25 each, total $1.1M) Filed: Jan 09, 2026 | ID: 000008

Comment Full text

Neumora Therapeutics Inc. (NMRA)

  • SEC News
  • Jan. 09, 2026, 21:18 UTC
  • 5
  • 1 comments

Pinto Joshua 🟢 acquired 1.2M shares (1 derivative) of Neumora Therapeutics, Inc. (NMRA) at $2.33 ($2.8M) Transaction Date: Jan 08, 2026 | Filing ID: 000009

Comment Full text

Charles River Laboratories International Inc. (CRL)

  • SEC News
  • Jan. 09, 2026, 21:18 UTC
  • 7
  • 1 comments

(99% Neutral) CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Announces New Board Appointment

Comment Full text

Neumora Therapeutics Inc. (NMRA)

  • SEC News
  • Jan. 09, 2026, 21:17 UTC
  • 7
  • 1 comments

BERNS PAUL L 🟢 acquired 1.6M shares (1 derivative) of Neumora Therapeutics, Inc. (NMRA) at $2.33 ($3.8M) Transaction Date: Jan 08, 2026 | Filing ID: 000008

Comment Full text

Collplant Biotechnologies Ltd (CLGN)

  • SEC News
  • Jan. 09, 2026, 21:16 UTC
  • 5
  • 0 comments

New Form F-3 - CollPlant Biotechnologies Ltd Filed: 2026-01-09 AccNo: 0001213900-26-002932 Size: 780 KB

Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • SEC News
  • Jan. 09, 2026, 21:16 UTC
  • 10
  • 0 comments

New Form DEF 14A - Karyopharm Therapeutics Inc. Filed: 2026-01-09 AccNo: 0001193125-26-008939 Size: 4 MB

Comment Full text
  • Previous
  • 343
  • 344
  • 345
  • 346
  • 347
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2315)
  • SEC News(190439)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124851)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin